My HPRA: Register

Latest Updates

Safety Notices
01.06.2018
Summary of Field Safety Notices - May 2018
Publications & Forms
31.05.2018
Guide to Interchangeable Medicines
Safety Notices
29.05.2018
Aquilon series of nebulisers - Priority 1 - For Immediate Action
Safety Notices
28.05.2018
Granulocyte colony-stimulating factors (G-CSFs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim) - Important Safety Information from Amgen Europe B.V, Chugai Pharma UK, Teva, Apotex Europe B.V, and Accord Healthcare Ltd as approved by the HPRA
Safety Notices
25.05.2018
Tivicay (dolutegravir), Triumeq (dolutegravir, abacavir, lamivudine), Juluca (dolutegravir, rilpivirine) - Important Safety Information from Viiv Healthcare as approved by the HPRA
Safety Notices
24.05.2018
HPRA MIMS Article May 2018 Valproate (Epilim) - New contraindications, strengthened warnings and measures to prevent exposure during pregnancy
Safety Notices
24.05.2018
HPRA MIMS Article February 2018 Educational Materials and Tools published on HPRA website
Safety Notices
24.05.2018
HPRA MIMS article January 2018 Quinine. Reminder of safety profile and potential drug drug interactions particularly where used for nocturanl cramps
Safety Notices
24.05.2018
HPRA MIMS Article December 2017 New CPD e-learning module on reporting suspected adverse drug reactions
Publications & Forms
22.05.2018
Guide to the Notification System for Exempt Medicinal Products
« First« Previous12345678Next »Last »